SOPHiA GENETICSTM Myeloid Solution
Characterize key biomarkers with our comprehensive research application covering 30 genes associated with myelo- dysplastic syndromes, myeloproliferative neoplasms, and leukemia. This all-in-one solution enables assessment of DNA alterations aligned with key guidelines, including challenging genes (CALR, CEBPA, ASXL1, FLT3, including internal tandem duplications).
![](https://www.sophiagenetics.com/wp-content/uploads/2021/05/Myeloid-Mockup-Screen@4x.png.webp)